This podcast episode explores the societal safety implications of cannabinoids and psychedelics, covering key topics like addiction potential, psychological risks, and substance misuse. The discussion examines how regulatory frameworks and quality control measures like cGMP compliance can help ensure public safety. The episode also delves into the FDA's role in drug approval, the importance of accurate labeling, and the broader ethical considerations of integrating these substances into mainstream use.